Are the recommendations to use perioperative -blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?
Open Access
- 3 August 2004
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (3) , 245-247
- https://doi.org/10.1503/cmaj.1031619
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic ReviewAnesthesia & Analgesia, 2003
- Be skeptical about unexpected large apparent treatment effects:Controlled Clinical Trials, 2003
- ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summaryJournal of the American College of Cardiology, 2002
- The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular SurgeryNew England Journal of Medicine, 1999
- Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac SurgeryCirculation, 1999
- Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac SurgeryNew England Journal of Medicine, 1996
- The Effects of Different Anesthetic Regimens on Fibrinolysis and the Development of Postoperative Arterial ThrombosisAnesthesiology, 1993
- Perioperative Cardiac MorbidityAnesthesiology, 1990
- Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstructionJournal of Vascular Surgery, 1984
- Sequential changes in coagulation and platelet function following femorotibial bypassJournal of Vascular Surgery, 1984